194 related articles for article (PubMed ID: 35800446)
1. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis.
Xie S; Xu F; Lu Y; Zhang Y; Li X; Yu M; Cui W
Front Pharmacol; 2022; 13():890881. PubMed ID: 35800446
[TBL] [Abstract][Full Text] [Related]
2. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
3. Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells.
Kang SH; Kim SW; Kim KJ; Cho KH; Park JW; Kim CD; Do JY
Kidney Res Clin Pract; 2019 Dec; 38(4):472-480. PubMed ID: 31554027
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
5. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
6. Autophagy caused by oxidative stress promotes TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
Oh SH; Yook JM; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Lim JH
Cell Death Dis; 2024 May; 15(5):365. PubMed ID: 38806451
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
[TBL] [Abstract][Full Text] [Related]
8. Paricalcitol ameliorates epithelial-to-mesenchymal transition in the peritoneal mesothelium.
Kang SH; Kim SO; Cho KH; Park JW; Yoon KW; Do JY
Nephron Exp Nephrol; 2014; 126(1):1-7. PubMed ID: 24458092
[TBL] [Abstract][Full Text] [Related]
9. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells.
Shin HS; Ryu ES; Oh ES; Kang DH
Lab Invest; 2015 Oct; 95(10):1157-73. PubMed ID: 26192086
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway.
Heo JY; Do JY; Lho Y; Kim AY; Kim SW; Kang SH
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356903
[TBL] [Abstract][Full Text] [Related]
12. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
13. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
14. Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling.
Huang Q; Xiao R; Lu J; Zhang Y; Xu L; Gao J; Sun J; Wang H
Front Pharmacol; 2022; 13():973182. PubMed ID: 36210850
[No Abstract] [Full Text] [Related]
15. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
16. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
17. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence.
Kawka E; Witowski J; Sandoval P; Rudolf A; Vidal AR; Cabrera ML; Jörres A
Perit Dial Int; 2019; 39(1):35-41. PubMed ID: 30478141
[TBL] [Abstract][Full Text] [Related]
19. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.
Han SM; Ryu HM; Suh J; Lee KJ; Choi SY; Choi S; Kim YL; Huh JY; Ha H
Sci Rep; 2019 Feb; 9(1):1497. PubMed ID: 30728376
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
